NCT00154791View on ClinicalTrials.gov

Phase I/II Trial GOFL in Advanced Pancreatic Adenocarcinoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

August 31, 2005

Conditions
Pancreatic Adenocarcinoma
Interventions
DRUG

oxaliplatin

DRUG

gemcitabine

DRUG

5-FU/LV

Trial Locations (1)

100

National Taiwan Univeristy Hospital, Taipei

All Listed Sponsors
collaborator

National Health Research Institutes, Taiwan

OTHER

lead

National Taiwan University Hospital

OTHER

NCT00154791 - Phase I/II Trial GOFL in Advanced Pancreatic Adenocarcinoma | Biotech Hunter | Biotech Hunter